Reports Q2 revenue $1.67B, consensus $1.65B. “Our second quarter results were mixed, given the challenging end market environment,” said Don Zurbay, president and CEO of Patterson Companies (PDCO). “To support sustainable, long-term growth, we took dedicated cost management actions to optimize our operations, made targeted investments in complementary businesses and invested in enhancing our higher margin products and services. As we continue to execute on our strategy, we remain confident in the opportunities within our end markets and our ability to meet the evolving needs of our dental and animal health customers and to drive improved performance.”
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- GE Vernova initiated, Merck upgraded: Wall Street’s top analyst calls
- Patterson Companies initiated with a Neutral at Mizuho
- Patterson Companies price target trimmed to $28 at Leerink ahead of earnings
- PDCO Upcoming Earnings Report: What to Expect?
- Patterson Dental Supply extends strategic relationship with PDS Health